Optimal Application Dose of Superficial Hyperthermia
NCT00766233
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Tumors
Interventions
OTHER:
Hyperthermal treatment
Sponsor
Universitätsmedizin Mannheim